BBL
MRNA icon

Beck Bode LLC’s Moderna MRNA Stock Holding History

Beck Bode LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,842
Closed -$331K – 170
2022
Q4 		$331K Sell
1,842
-3,947
-68% -$645K 0.07% 131
2022
Q3 		$685K Sell
5,789
-112
-2% -$17K 0.15% 113
2022
Q2 		$843K Buy
5,901
+511
+9% +$73K 0.18% 97
2022
Q1 		$928K Buy
+5,390
New +$907K 0.21% 74
2021
Q3 		– Sell
-206
Closed -$48K – 213
2021
Q2 		$48K Buy
+206
New +$36.8K 0.01% 134
2020
Q4 		– Sell
-100
Closed -$7K – 170
2020
Q3 		$7K Buy
+100
New +$6.97K ﹤0.01% 227

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return